Showing results (351-360 of 402) with videos related to
Sort By:
Pageof 41
British Journal of Cancer|October 23, 2015
Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patientsFrede Donskov, M Dror Michaelson, Igor Puzanov, et al.Oncogene|July 26, 2022
Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patientsLiuyang Zhao, Xiang Zhang, Yunfei Zhou, et al.Clinical Genitourinary Cancer|January 24, 2018
The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported CasesMariuxi A Viteri Malone, Gustavo Ruiz Ares, Guillermo De Velasco, et al.Nature Communications|March 12, 2021
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulationYilei Zhang, Robert V Swanda, Litong Nie, et al.RSC Advances|May 11, 2022
Photoluminescence mechanism and applications of Zn-doped carbon dotsQuan Xu, Wei Cai, Miaoran Zhang, et al.European Journal of Cancer (Oxford, England : 1990)|November 16, 2021
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and regionUgo De Giorgi, Maha Hussain, Neal Shore, et al.Future Oncology (London, England)|October 13, 2022
Which traits affect how long patients with advanced prostate cancer live when treated with enzalutamide?Ugo De Giorgi, Maha Hussain, Neal Shore, et al.Nature Cell Biology|April 2, 2020
Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancerXiaoguang Liu, Kellen Olszewski, Yilei Zhang, et al.Future Oncology (London, England)|August 11, 2022
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancerNeeraj Agarwal, Arun Azad, Neal D Shore, et al.Journal of Translational Medicine|July 27, 2011
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibCharles S Harmon, Samuel E DePrimo, Eric Raymond, et al.Pageof 41